Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs: 1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

"Nefecon®","Ambrisentan"

The First People's Hospital of Lianyungang

IgA Nephropathy

approved small molecule active

1 trial
"Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

Takeda

Cramps

approved small molecule completed

1 trial
-

The George Institute

Acute lower Respiratory Tract Infection or acute rhinosinusitis

approved small molecule active

1 trial
-, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM

Pari Pharma GmbH

Pyelonephritis, Kidney Transplant recipients

approved small molecule active

1 trial
-, IPTACOPAN, -, -, -

Novartis Pharmaceuticals

IgA Nephropathy

approved small molecule active

1 trial
0.1% bromfenac

Zhongshan Ophthalmic Center, Sun Yat-sen University

Pterygium

approved small molecule completed

1 trial
0.1% bupivacaine

United Therapeutics Europe Ltd

Pregnancy

approved small molecule active

1 trial
0.3% ropivacaine and 50 μg dexmedetomidine

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Free Flap Reconstruction

approved small molecule active

1 trial
0.33% ropivacaine 250ml

Guangzhou General Hospital of Guangzhou Military Command

Pain

approved small molecule completed

1 trial
0.9% Sodium Chloride Injection

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Unstable Angina

approved small molecule active

1 trial
1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

Takeda

Prostate or Bladder Cancer

approved small molecule completed

1 trial
1-84 parathyroid hormone

Takeda

Shoulder Fractures

approved small molecule active

1 trial
100mg SPN-812

SUPERNUS PHARMACEUTICALS, INC.

Attention-Deficit/Hyperactivity Disorder

approved small molecule active

1 trial
16 mg buprenorphine with 4 mg naloxone sublingual film

Teva Pharma GmbH

Evaluation of QTc Interval

approved other terminated

1 trial
18F-Canagliflozin, Invokana 300 mg film-coated tablets

Disc Medicine

Chronic Kidney disease

approved small molecule active

1 trial
2 doses of HAV

Sinovac Research and Development Co.,

Hepatitis A

approved mab completed

1 trial
2.0mg Buprenorphine/0.5mg Naloxone

Indivior Pty Ltd

Hepatic Failure

approved small molecule completed

1 trial
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Hepatitis B Vaccine

approved mab active

3 trials
2012-2013 trivalent seasonal influenza vaccine

Sinovac Research and Development Co.,

Influenza

approved mab completed

1 trial
20mg Febuxostat

The First People's Hospital of Lianyungang

Hyperuricemia

approved small molecule active

1 trial
23-valent pneumococcal polysaccharide vaccine

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Vaccination

approved mab completed

1 trial
2wIPV+1sIPV

Sinovac Research and Development Co.,

Poliomyelitis

approved mab active

1 trial
2wIPV+1sIPV

Biotech Pharmaceutical Co.,

Poliomyelitis

approved mab active

1 trial
3 % Minoxidil lotion

Hospital Authority, Hong Kong

Beard Enhancement

approved small molecule completed

1 trial
30% Oxygen

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Atelectasis

approved small molecule completed

1 trial
30%Oxygen

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Atelectasis, Postoperative

approved small molecule completed

1 trial
37.5mg Pregabalin + 75mg Pregabalin

The First People's Hospital of Lianyungang

Pain, Postoperative

approved small molecule completed

1 trial
400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

BRIGHT MINDS BIOSCIENCES INC.

Benign Paroxysmal Positional Vertigo

approved small molecule completed

1 trial
50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

Pacira Ireland Limited

Elective Cesarean Section

approved small molecule completed

1 trial
50,000 Units Ergocalciferol

United Therapeutics Europe Ltd

Pruritis

approved small molecule completed

1 trial
5000 volunteers (6-35 months)-EV71 vaccine

Sinovac Research and Development Co.,

Hand, Foot and Mouth Disease

approved mab completed

1 trial
6-month clopidogrel therapy

Hospital Authority, Hong Kong

Coronary Artery Disease

approved small molecule completed

1 trial
60 µg dose hepatitis B vaccine

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Hepatitis B Vaccine

approved mab completed

1 trial
60 µg dose hepatitis B vaccine

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Hepatitis B Vaccination

approved mab completed

1 trial
80% Oxygen

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Oxygenation Index

approved small molecule active

1 trial
99mTc-Macro Albumin Aggregate

BRIGHT MINDS BIOSCIENCES INC.

Carcinoma

approved small molecule completed

1 trial
A-101 Topical Solution

Aclaris Therapeutics

Seborrheic Keratosis

approved small molecule completed

1 trial
ABBV-066, DEUCRAVACITINIB

AbbVie Deutschland GmbH & Co. KG

Plaque Psoriasis

approved small molecule active

1 trial
ACEI / ARB+finerenone

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Henoch Schönlein Purpura Nephritis

approved small molecule active

1 trial
ACETYLSALICYLIC ACID

The George Institute

Obstetrics – Preeclampsia

approved small molecule active

1 trial
ACETYLSALICYLIC ACID , CLOPIDOGREL , RIVAROXABAN

Disc Medicine

Peripheral Arterial Disease

approved small molecule active

1 trial
ACETYLSALICYLIC ACID , PRASUGREL , METOPROLOL , PROPRANOLOL , ATENOLOL , CARVEDILOL , CLOPIDOGREL , BISOPROLOL , TICAGRELOR

Cardiol Therapeutics

Spontaneous Coronary Artery Dissection.

approved small molecule active

1 trial
ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, CLOPIDOGREL, CLOPIDOGREL

Fondazione Telethon ETS

Patients with Stable or Unstable coronary syndromes who have undergone successful PCI

approved small molecule active

1 trial
ACETYLSALICYLIC ACID, PRASUGREL

Cardiol Therapeutics

St-Elevated Myocardial Infartion

approved small molecule active

1 trial
AD-4833 15 mg

Takeda

Diabetes Mellitus

approved small molecule completed

1 trial
ADALIMUMAB , INFLIXIMAB

Disc Medicine

Crohn's disease Ulcerative colitis

approved small molecule active

1 trial
ADALIMUMAB, BARICITINIB, BARICITINIB, ADALIMUMAB, ETANERCEPT

Eli Lilly Co.

Rheumatoid Arthritis

approved small molecule active

1 trial
ADVAGRAF

Astellas Pharma Inc

Renal Transplantation

approved small molecule completed

1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Quick answer

Top sponsors

"Nefecon®","Ambrisentan"

"Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

-

-, -, SULFAMETHOXAZOLE AND TRIMETHOPRIM

-, IPTACOPAN, -, -, -

0.1% bromfenac

0.1% bupivacaine

0.3% ropivacaine and 50 μg dexmedetomidine

0.33% ropivacaine 250ml

0.9% Sodium Chloride Injection

1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

1-84 parathyroid hormone

100mg SPN-812

16 mg buprenorphine with 4 mg naloxone sublingual film

18F-Canagliflozin, Invokana 300 mg film-coated tablets

2 doses of HAV

2.0mg Buprenorphine/0.5mg Naloxone

20 µg recombinant hepatitis B vaccine at months 0, 1, and 6

2012-2013 trivalent seasonal influenza vaccine

20mg Febuxostat

23-valent pneumococcal polysaccharide vaccine

2wIPV+1sIPV

2wIPV+1sIPV

3 % Minoxidil lotion

30% Oxygen

30%Oxygen

37.5mg Pregabalin + 75mg Pregabalin

400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

50,000 Units Ergocalciferol

5000 volunteers (6-35 months)-EV71 vaccine

6-month clopidogrel therapy

60 µg dose hepatitis B vaccine

60 µg dose hepatitis B vaccine

80% Oxygen

99mTc-Macro Albumin Aggregate

A-101 Topical Solution

ABBV-066, DEUCRAVACITINIB

ACEI / ARB+finerenone

ACETYLSALICYLIC ACID

ACETYLSALICYLIC ACID , CLOPIDOGREL , RIVAROXABAN

ACETYLSALICYLIC ACID , PRASUGREL , METOPROLOL , PROPRANOLOL , ATENOLOL , CARVEDILOL , CLOPIDOGREL , BISOPROLOL , TICAGRELOR

ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, CLOPIDOGREL, CLOPIDOGREL

ACETYLSALICYLIC ACID, PRASUGREL

AD-4833 15 mg

ADALIMUMAB , INFLIXIMAB

ADALIMUMAB, BARICITINIB, BARICITINIB, ADALIMUMAB, ETANERCEPT

ADVAGRAF

Frequently asked questions

Stay Ahead in Pharma